Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SSII vs ISRG vs SYK vs MDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SSII
SS Innovations International, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$763M
5Y Perf.+1504.1%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$112.69B
5Y Perf.+50.3%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-20.9%

SSII vs ISRG vs SYK vs MDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SSII logoSSII
ISRG logoISRG
SYK logoSYK
MDT logoMDT
IndustryMedical - DevicesMedical - Instruments & SuppliesMedical - DevicesMedical - Devices
Market Cap$763M$161.07B$112.69B$99.94B
Revenue (TTM)$42M$10.58B$25.12B$35.48B
Net Income (TTM)$-12M$2.98B$3.25B$4.61B
Gross Margin46.0%66.3%63.5%61.9%
Operating Margin-19.2%30.5%22.4%17.9%
Forward P/E43.8x19.6x14.1x
Total Debt$3M$303M$14.86B$28.52B
Cash & Equiv.$3M$3.37B$4.01B$2.22B

SSII vs ISRG vs SYK vs MDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SSII
ISRG
SYK
MDT
StockMay 20May 26Return
SS Innovations Inte… (SSII)1001604.1+1504.1%
Intuitive Surgical,… (ISRG)100234.6+134.6%
Stryker Corporation (SYK)100150.3+50.3%
Medtronic plc (MDT)10079.1-20.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: SSII vs ISRG vs SYK vs MDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and dividend income and shareholder returns. SS Innovations International, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. ISRG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
SSII
SS Innovations International, Inc.
The Growth Play

SSII is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.

  • Rev growth 105.7%, EPS growth 40.0%, 3Y rev CAGR 207.7%
  • Lower volatility, beta 0.01, Low D/E 7.6%, current ratio 1.86x
  • 105.7% revenue growth vs MDT's 3.6%
  • Beta 0.01 vs ISRG's 1.02
Best for: growth exposure and sleep-well-at-night
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG is the clearest fit if your priority is long-term compounding.

  • 5.5% 10Y total return vs SSII's 162.0%
  • 28.2% margin vs SSII's -28.5%
Best for: long-term compounding
SYK
Stryker Corporation
The Value Pick

SYK is the clearest fit if your priority is valuation efficiency.

  • PEG 1.32 vs MDT's 36.00
Best for: valuation efficiency
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Lower P/E (14.1x vs 43.8x)
  • 3.6% yield, 36-year raise streak, vs SYK's 1.1%, (2 stocks pay no dividend)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthSSII logoSSII105.7% revenue growth vs MDT's 3.6%
ValueMDT logoMDTLower P/E (14.1x vs 43.8x)
Quality / MarginsISRG logoISRG28.2% margin vs SSII's -28.5%
Stability / SafetySSII logoSSIIBeta 0.01 vs ISRG's 1.02
DividendsMDT logoMDT3.6% yield, 36-year raise streak, vs SYK's 1.1%, (2 stocks pay no dividend)
Momentum (1Y)MDT logoMDT-2.8% vs SSII's -61.3%
Efficiency (ROA)MDT logoMDT175.8% ROA vs SSII's -17.5%, ROIC 6.0% vs -17.7%

SSII vs ISRG vs SYK vs MDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SSIISS Innovations International, Inc.
FY 2025
System Sales Member
100.0%$38M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B

SSII vs ISRG vs SYK vs MDT — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSYK

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 835.2x SSII's $42M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SSII's -28.5%. On growth, SSII holds the edge at +158.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
RevenueTrailing 12 months$42M$10.6B$25.1B$35.5B
EBITDAEarnings before interest/tax-$7M$3.8B$6.3B$9.4B
Net IncomeAfter-tax profit-$12M$3.0B$3.2B$4.6B
Free Cash FlowCash after capex-$22M$2.8B$4.3B$5.4B
Gross MarginGross profit ÷ Revenue+46.0%+66.3%+63.5%+61.9%
Operating MarginEBIT ÷ Revenue-19.2%+30.5%+22.4%+17.9%
Net MarginNet income ÷ Revenue-28.5%+28.2%+12.9%+13.0%
FCF MarginFCF ÷ Revenue-52.3%+26.8%+17.1%+15.2%
Rev. Growth (YoY)Latest quarter vs prior year+158.4%+23.0%+11.4%+8.8%
EPS Growth (YoY)Latest quarter vs prior year+69.0%+18.8%+56.0%-11.9%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

MDT leads this category, winning 5 of 7 comparable metrics.

At 21.6x trailing earnings, MDT trades at a 63% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), SYK offers better value at 2.36x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Market CapShares × price$763M$161.1B$112.7B$99.9B
Enterprise ValueMkt cap + debt − cash$763M$158.0B$123.5B$126.2B
Trailing P/EPrice ÷ TTM EPS-65.50x57.62x35.03x21.60x
Forward P/EPrice ÷ next-FY EPS est.43.84x19.62x14.13x
PEG RatioP/E ÷ EPS growth rate2.65x2.36x36.00x
EV / EBITDAEnterprise value multiple43.62x20.31x14.32x
Price / SalesMarket cap ÷ Revenue17.96x16.00x4.49x2.98x
Price / BookPrice ÷ Book value/share20.43x9.17x5.02x2.08x
Price / FCFMarket cap ÷ FCF64.67x26.31x19.28x
MDT leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 6 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-30 for SSII. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SYK's 0.66x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs SSII's 5/9, reflecting solid financial health.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
ROE (TTM)Return on equity-30.2%+16.9%+15.0%+9.4%
ROA (TTM)Return on assets-17.5%+14.8%+6.9%+175.8%
ROICReturn on invested capital-17.7%+15.0%+11.4%+6.0%
ROCEReturn on capital employed-23.6%+16.5%+13.0%+7.5%
Piotroski ScoreFundamental quality 0–95666
Debt / EquityFinancial leverage0.08x0.02x0.66x0.59x
Net DebtTotal debt minus cash-$289,540-$3.1B$10.8B$26.3B
Cash & Equiv.Liquid assets$3M$3.4B$4.0B$2.2B
Total DebtShort + long-term debt$3M$303M$14.9B$28.5B
Interest CoverageEBIT ÷ Interest expense-7.35x6.72x9.08x
ISRG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SSII leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in SSII five years ago would be worth $38,155 today (with dividends reinvested), compared to $7,230 for MDT. Over the past 12 months, MDT leads with a -2.8% total return vs SSII's -61.3%. The 3-year compound annual growth rate (CAGR) favors SSII at 82.1% vs MDT's -1.4% — a key indicator of consistent wealth creation.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
YTD ReturnYear-to-date-30.4%-19.3%-15.2%-18.1%
1-Year ReturnPast 12 months-61.3%-15.4%-22.5%-2.8%
3-Year ReturnCumulative with dividends+503.7%+49.6%+5.5%-4.2%
5-Year ReturnCumulative with dividends+281.6%+58.7%+21.5%-27.7%
10-Year ReturnCumulative with dividends+162.0%+554.2%+187.1%+26.5%
CAGR (3Y)Annualised 3-year return+82.1%+14.4%+1.8%-1.4%
SSII leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SSII and ISRG each lead in 1 of 2 comparable metrics.

SSII is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than ISRG's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISRG currently trades 75.1% from its 52-week high vs SSII's 33.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Beta (5Y)Sensitivity to S&P 5000.01x1.02x0.55x0.47x
52-Week HighHighest price in past year$11.87$603.88$404.87$106.33
52-Week LowLowest price in past year$3.02$427.84$289.91$77.16
% of 52W HighCurrent price vs 52-week peak+33.1%+75.1%+72.7%+73.3%
RSI (14)Momentum oscillator 0–10039.142.424.327.3
Avg Volume (50D)Average daily shares traded54K1.8M2.1M7.8M
Evenly matched — SSII and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: ISRG as "Buy", SYK as "Buy", MDT as "Buy". Consensus price targets imply 40.5% upside for MDT (target: $110) vs 37.2% for SYK (target: $404). For income investors, MDT offers the higher dividend yield at 3.57% vs SYK's 1.14%.

MetricSSII logoSSIISS Innovations In…ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$622.60$403.69$109.50
# AnalystsCovering analysts555049
Dividend YieldAnnual dividend ÷ price+1.1%+3.6%
Dividend StreakConsecutive years of raises3436
Dividend / ShareAnnual DPS$3.36$2.78
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%0.0%+3.2%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MDT leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

SSII vs ISRG vs SYK vs MDT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SSII or ISRG or SYK or MDT a better buy right now?

For growth investors, SS Innovations International, Inc.

(SSII) is the stronger pick with 105. 7% revenue growth year-over-year, versus 3. 6% for Medtronic plc (MDT). Medtronic plc (MDT) offers the better valuation at 21. 6x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SSII or ISRG or SYK or MDT?

On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.

6x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Medtronic plc is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 32x versus Medtronic plc's 36. 00x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — SSII or ISRG or SYK or MDT?

Over the past 5 years, SS Innovations International, Inc.

(SSII) delivered a total return of +281. 6%, compared to -27. 7% for Medtronic plc (MDT). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus MDT's +26. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SSII or ISRG or SYK or MDT?

By beta (market sensitivity over 5 years), SS Innovations International, Inc.

(SSII) is the lower-risk stock at 0. 01β versus Intuitive Surgical, Inc. 's 1. 02β — meaning ISRG is approximately 6974% more volatile than SSII relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — SSII or ISRG or SYK or MDT?

By revenue growth (latest reported year), SS Innovations International, Inc.

(SSII) is pulling ahead at 105. 7% versus 3. 6% for Medtronic plc (MDT). On earnings-per-share growth, the picture is similar: SS Innovations International, Inc. grew EPS 40. 0% year-over-year, compared to 8. 2% for Stryker Corporation. Over a 3-year CAGR, SSII leads at 207. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SSII or ISRG or SYK or MDT?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -28. 5% for SS Innovations International, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -19. 2% for SSII. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SSII or ISRG or SYK or MDT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 32x versus Medtronic plc's 36. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Medtronic plc (MDT) trades at 14. 1x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 29. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.

08

Which pays a better dividend — SSII or ISRG or SYK or MDT?

In this comparison, MDT (3.

6% yield), SYK (1. 1% yield) pay a dividend. SSII, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is SSII or ISRG or SYK or MDT better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

55), 1. 1% yield, +187. 1% 10Y return). Both have compounded well over 10 years (SYK: +187. 1%, ISRG: +554. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SSII and ISRG and SYK and MDT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SSII is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock. SYK, MDT pay a dividend while SSII, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SSII

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 79%
  • Gross Margin > 27%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SSII and ISRG and SYK and MDT on the metrics below

Revenue Growth>
%
(SSII: 158.4% · ISRG: 23.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.